Services Agreement for the production of fill finished vaccines for COVID-19 and therapeutics for use in the UK health system
key details
| Value | £50,000,000 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Deadline | 17 Jul 2020 |
| Contract start | 1 Aug 2020 |
| Contract end | 1 Feb 2022 |
| Procedure | limited |
| SME suitable | No |
| OCID | ocds-b5fd17-ac189eb4-f053-4202-9ceb-03425dd56f3e |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| C P PHARMACEUTICALS LIMITED | £50,000,000 | 30 Jul 2020 | active |
description
The reservation of fill & finish manufacturing capacity at C P Pharmaceutical's Wrexham site for 18 months, which will provide capacity for vaccine in bulk product form to be converted into individual doses capable of roll out via a mass vaccination programme.
Additional information: This Contract Award Notice supersedes the already published notice that exists for this requirement, which can be found in the "links" section of this notice. This Award Notice has been published in order to include a redacted copy of the contract. This does not constitute an additional or separate agreement, and is merely a republication of the original notice.
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 7 Oct 2020 | Award (award) | · | f2e8974a-6658-4314-8d28-2cf8725875a2-384333 |
more from Business Energy and Industrial Strategy
- Delivery Partner 2 (DP2) - WH:SHF and WH:LG · 11 Sept 2025
- Heat Network Efficiency Scheme - HNES MAIN · £2,961,208 · 5 Nov 2024
- Re-procurement of Hydrogen Legal Advisors · 1 May 2024
- Technical Assistance Facility 2 - Pre-Tender Market Engagement · 14 Aug 2023
- APGB Reprocurement - Suppliers Event · 6 Jul 2023
- Medicines Manufacturing Skills and Training Consultation · 21 Apr 2023
- Sizewell C Legal Services Contract · £7,500,000 · 31 Mar 2023
- Local Authority 'Capability' and 'Capacity' Building Grant Funding Pilot Evaluation · 9 Feb 2023
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.